Sumary of Global Antibody Partnering Deals, Terms and Agreements Report 2021:
- The Global Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies..
- The report provides a detailed understanding and analysis of how and why companies enter Antibody partnering deals..
- The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Antibody technology..
- Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms..
- Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not..
- This report contains over 1,800 links to online copies of actual Antibody deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners….